Showing results (1051-1060 of 1,172) with videos related to

Sort By:
Pageof 118
British Journal of Haematology|May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphomaNarendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Therapie|August 8, 2014
Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situationsMathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical featuresR Vaidya, T M Habermann, J H Donohue, et al.
American Journal of Hematology|September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphomaThomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2021
Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell LymphomaMadiha Iqbal, Yennifer Gil Castano, Jonas Paludo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2012
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilizationIvana N M Micallef, Shirshendu Sinha, Dennis A Gastineau, et al.
Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.
Blood Cancer Journal|May 3, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohortsSanjal H Desai, Levi Pederson, Betsy LaPlant, et al.
Scientific Reports|June 21, 2018
Adaptability and reproducibility of a memory disruption rTMS protocol in the PharmaCog IMI European projectPablo Martin-Trias, Laura Lanteaume, Elisabeth Solana, et al.
The Lancet Regional Health. Europe|May 4, 2022
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance studyNaïm Ouldali, Haleh Bagheri, Francesco Salvo, et al.
Pageof 118